Skip Navigation
ChemIDplus A TOXNET DATABASE LiteBrowseAdvanced

Substance Name: Calcium acetate [USP:JAN]
RN: 62-54-4
UNII: Y882YXF34X
InChIKey: VSGNNIFQASZAOI-UHFFFAOYSA-L

Note

  • A principal compound used as phosphate binders in patients with chronic renal failure; used like sevelamer.

Molecular Formula

  • C2-H4-O2.1/2Ca

Molecular Weight

  • 158.1654
 

Classification Codes

  • Chelating Agents
  • Mutation Data
  • Pharmaceutic Aid (Buffering Agent)
  • Sequestering Agents

Names and Synonyms

Name of Substance

  • Acetic acid, calcium salt
  • Calcium acetate
  • Calcium acetate [USP:JAN]

Synonyms

  • Acetate of lime
  • Acetic acid, calcium salt
  • AI3-02903
  • Brown acetate
  • Brown Acetate of Lime
  • Calcium acetate
  • Calcium diacetate
  • CCRIS 4921
  • EC 200-540-9
  • EINECS 200-540-9
  • FEMA No. 2228
  • Gray acetate
  • Gray Acetate of Lime
  • HSDB 928
  • Lime acetate
  • Lime pyrolignite
  • PhosLo
  • Phoslo gelcaps
  • Phoslyra
  • Sanopan
  • Sorbo-calcion
  • Teltozan
  • UNII-Y882YXF34X
  • Vinegar salts

Systematic Names

  • Acetic acid, calcium salt
  • Acetic acid, calcium salt (2:1)
  • Calcium acetate
  • Calcium di(acetate)

Superlist Names

  • Acetate of lime
  • Calcium acetate
  • Vinegar salts

Registry Numbers

CAS Registry Number

  • 62-54-4

FDA UNII

  • Y882YXF34X

System Generated Number

  • 0000062544

Molecular Formulas

Molecular Formula

  • C2-H4-O2.1/2Ca

Molecular Formula Fragments

  • C2-H4-O2
  • Ca
  • COMPONENT

Structure Descriptors

InChI

1S/2C2H4O2.Ca/c2*1-2(3)4;/h2*1H3,(H,3,4);/q;;+2/p-2

InChIKey

VSGNNIFQASZAOI-UHFFFAOYSA-L

Smiles

[Ca+2].CC(=O)[O-].CC(=O)[O-]

Toxicity

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
mouse LD50 intraperitoneal 75mg/kg (75mg/kg)   Acta Biologica et Medica Germanica. Vol. 6, Pg. 447, 1961.
mouse LD50 intravenous 203mg/kg (203mg/kg)   Journal of Laboratory and Clinical Medicine. Vol. 29, Pg. 809, 1944.
rat LDLo intravenous 147mg/kg (147mg/kg)   Journal of Pharmacology and Experimental Therapeutics. Vol. 71, Pg. 1, 1941.